Of the 3,297, we estimate that 2,490 MIPS eligible clinicians or groups will submit a request that includes reweighting the Promoting Interoperability performance category to zero percent due to a significant hardship or other exception as provided in 414.1380(c)(2)(i)(C)
We have heard from interested parties that Blood-based Biomarker tests for CRC screening may achieve the coverage requirements described in NCD 210.3 within the near term and thereafter quickly become adopted as a non-invasive option within the healthcare system and patient community
CMS proposes in proposed 427.501 that the multi-step reporting process for providing rebate information to a manufacturer would include: (1) an initial report, which CMS proposes to entitle the Preliminary Rebate Report in proposed 427.501(b) and (2) a second report, which CMS proposes to entitle the Rebate Report in proposed 427.501(c)
They can affect your entire body
We propose including Respiratory Infection Hospitalization as a care episode group and CKD, ESRD, Kidney Transplant Management, Prostate Cancer, and Rheumatoid Arthritis as patient condition groups
